Skip to content
Screener

Opko Health OPK Total Liabilities

Total Liabilities at other companies

Regenxbio logo
RegenxbioRGNX
$314.85M-14.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$104.71M-33.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1.55B+34.8%
PTH
Pelthos TherapeuticsPTHS
$110.28M+2,059%
Exelixis logo
ExelixisEXEL
$650.47M+0.9%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$37.86M-7.2%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$985.15M-2.3%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemJune 30, 2026December 31, 2025
Deferred tax liabilities108,230126,241
Other long-term liabilities16,99922,799
Total long-term liabilities495,920517,308
Total liabilities645,287663,985
Equity:
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 776,128,402 and 789,917,433 shares issued at June 30, 2026 and December 31, 2025, respectively7,7627,900
Treasury Stock - 30,174,907, and 30,849,907 shares at June 30, 2026 and December 31, 2025, respectively(2,363)(3,176)
Additional paid-in capital3,561,1143,574,942

Item 1. Financial Statements

FAQ

What is Opko Health's total liabilities?
Opko Health (OPK) reported total liabilities of $645.29M in Q2 2026.
How has Opko Health's total liabilities changed year-over-year?
Opko Health's total liabilities decreased by 4.6% year-over-year, from $676.09M to $645.29M.
What is the long-term trend for Opko Health's total liabilities?
Over 5 years (2020 to 2025), Opko Health's total liabilities has grown at a 150.5% compound annual growth rate (CAGR), from $6.74M to $663.99M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about Opko Health's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude